Similarly, in another study in 21 breast cancer patients, perfusion (Kep) and metabolic (SUVmax) parameters were found to be higher in hormone‐positive tumors compared to hormone‐negative tumors, while HER2+ lesions showed higher ADCmean, Kep, and SUVmax values than HER2− lesions.68 This evidence concerns the gene ERBB2 and breast cancer.